Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1876 1
1903 1
1904 1
1948 1
1956 1
1958 1
1960 1
1961 3
1963 2
1964 2
1965 1
1966 1
1967 4
1968 1
1969 1
1970 2
1971 3
1972 1
1973 5
1974 4
1975 3
1976 6
1977 7
1978 9
1979 11
1980 7
1981 4
1982 9
1983 10
1984 3
1985 9
1986 5
1987 6
1988 13
1989 8
1990 6
1991 9
1992 22
1993 11
1994 12
1995 15
1996 14
1997 17
1998 20
1999 15
2000 28
2001 20
2002 30
2003 30
2004 28
2005 33
2006 20
2007 22
2008 18
2009 34
2010 35
2011 28
2012 29
2013 29
2014 36
2015 35
2016 42
2017 51
2018 37
2019 42
2020 50
2021 57
2022 44
2023 44
2024 26

Text availability

Article attribute

Article type

Publication date

Search Results

1,048 results

Results by year

Filters applied: . Clear all
Page 1
Post-traumatic amnesia.
Parker TD, Rees R, Rajagopal S, Griffin C, Goodliffe L, Dilley M, Jenkins PO. Parker TD, et al. Pract Neurol. 2022 Apr;22(2):129-137. doi: 10.1136/practneurol-2021-003056. Epub 2021 Dec 14. Pract Neurol. 2022. PMID: 34906998
Oral Selinexor-Dexamethasone for Triple-Class Refractory Multiple Myeloma.
Chari A, Vogl DT, Gavriatopoulou M, Nooka AK, Yee AJ, Huff CA, Moreau P, Dingli D, Cole C, Lonial S, Dimopoulos M, Stewart AK, Richter J, Vij R, Tuchman S, Raab MS, Weisel KC, Delforge M, Cornell RF, Kaminetzky D, Hoffman JE, Costa LJ, Parker TL, Levy M, Schreder M, Meuleman N, Frenzel L, Mohty M, Choquet S, Schiller G, Comenzo RL, Engelhardt M, Illmer T, Vlummens P, Doyen C, Facon T, Karlin L, Perrot A, Podar K, Kauffman MG, Shacham S, Li L, Tang S, Picklesimer C, Saint-Martin JR, Crochiere M, Chang H, Parekh S, Landesman Y, Shah J, Richardson PG, Jagannath S. Chari A, et al. Among authors: parker tl. N Engl J Med. 2019 Aug 22;381(8):727-738. doi: 10.1056/NEJMoa1903455. N Engl J Med. 2019. PMID: 31433920 Clinical Trial.
Prognostic and Biologic Significance of ERBB2-Low Expression in Early-Stage Breast Cancer.
Tarantino P, Jin Q, Tayob N, Jeselsohn RM, Schnitt SJ, Vincuilla J, Parker T, Tyekucheva S, Li T, Lin NU, Hughes ME, Weiss AC, King TA, Mittendorf EA, Curigliano G, Tolaney SM. Tarantino P, et al. Among authors: parker t. JAMA Oncol. 2022 Aug 1;8(8):1177-1183. doi: 10.1001/jamaoncol.2022.2286. JAMA Oncol. 2022. PMID: 35737367 Free PMC article.
Carfilzomib or bortezomib in combination with lenalidomide and dexamethasone for patients with newly diagnosed multiple myeloma without intention for immediate autologous stem-cell transplantation (ENDURANCE): a multicentre, open-label, phase 3, randomised, controlled trial.
Kumar SK, Jacobus SJ, Cohen AD, Weiss M, Callander N, Singh AK, Parker TL, Menter A, Yang X, Parsons B, Kumar P, Kapoor P, Rosenberg A, Zonder JA, Faber E Jr, Lonial S, Anderson KC, Richardson PG, Orlowski RZ, Wagner LI, Rajkumar SV. Kumar SK, et al. Among authors: parker tl. Lancet Oncol. 2020 Oct;21(10):1317-1330. doi: 10.1016/S1470-2045(20)30452-6. Epub 2020 Aug 28. Lancet Oncol. 2020. PMID: 32866432 Free PMC article. Clinical Trial.
Redefine statistical significance.
Benjamin DJ, Berger JO, Johannesson M, Nosek BA, Wagenmakers EJ, Berk R, Bollen KA, Brembs B, Brown L, Camerer C, Cesarini D, Chambers CD, Clyde M, Cook TD, De Boeck P, Dienes Z, Dreber A, Easwaran K, Efferson C, Fehr E, Fidler F, Field AP, Forster M, George EI, Gonzalez R, Goodman S, Green E, Green DP, Greenwald AG, Hadfield JD, Hedges LV, Held L, Hua Ho T, Hoijtink H, Hruschka DJ, Imai K, Imbens G, Ioannidis JPA, Jeon M, Jones JH, Kirchler M, Laibson D, List J, Little R, Lupia A, Machery E, Maxwell SE, McCarthy M, Moore DA, Morgan SL, Munafó M, Nakagawa S, Nyhan B, Parker TH, Pericchi L, Perugini M, Rouder J, Rousseau J, Savalei V, Schönbrodt FD, Sellke T, Sinclair B, Tingley D, Van Zandt T, Vazire S, Watts DJ, Winship C, Wolpert RL, Xie Y, Young C, Zinman J, Johnson VE. Benjamin DJ, et al. Among authors: parker th. Nat Hum Behav. 2018 Jan;2(1):6-10. doi: 10.1038/s41562-017-0189-z. Nat Hum Behav. 2018. PMID: 30980045 Free article. No abstract available.
Cell competition and tumor heterogeneity.
Parker TM, Henriques V, Beltran A, Nakshatri H, Gogna R. Parker TM, et al. Semin Cancer Biol. 2020 Jun;63:1-10. doi: 10.1016/j.semcancer.2019.09.003. Epub 2019 Sep 9. Semin Cancer Biol. 2020. PMID: 31513848 Free article. Review.
Build up big-team science.
Coles NA, Hamlin JK, Sullivan LL, Parker TH, Altschul D. Coles NA, et al. Among authors: parker th. Nature. 2022 Jan;601(7894):505-507. doi: 10.1038/d41586-022-00150-2. Nature. 2022. PMID: 35079150 No abstract available.
Exaggerated effects in ecology.
Parker TH, Yang Y. Parker TH, et al. Nat Ecol Evol. 2023 Sep;7(9):1356-1357. doi: 10.1038/s41559-023-02156-z. Nat Ecol Evol. 2023. PMID: 37537386 No abstract available.
HIF-transcribed p53 chaperones HIF-1α.
Madan E, Parker TM, Pelham CJ, Palma AM, Peixoto ML, Nagane M, Chandaria A, Tomás AR, Canas-Marques R, Henriques V, Galzerano A, Cabral-Teixeira J, Selvendiran K, Kuppusamy P, Carvalho C, Beltran A, Moreno E, Pati UK, Gogna R. Madan E, et al. Among authors: parker tm. Nucleic Acids Res. 2019 Nov 4;47(19):10212-10234. doi: 10.1093/nar/gkz766. Nucleic Acids Res. 2019. PMID: 31538203 Free PMC article.
Optical-Clock-Based Time Scale.
Yao J, Sherman JA, Fortier T, Leopardi H, Parker T, McGrew W, Zhang X, Nicolodi D, Fasano R, Schäffer S, Beloy K, Savory J, Romisch S, Oates C, Diddams S, Ludlow A, Levine J. Yao J, et al. Among authors: parker t. Phys Rev Appl. 2019;12(4): Phys Rev Appl. 2019. PMID: 33102625 Free PMC article.
1,048 results